Indeed, the expression of A3C displayed positive correlations with CD274, PDCD1, PDCD1LG2, SIGLEC15, CTLA4, HAVCR2, and GZMB in glioma (P < 0.05; Figure 6D). This evidence concerns the gene SIGLEC15 and central nervous system cancer.